Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • 26 April 2010

    Indian pharma companies will become product companies, Reinhard Gluck, Cadila, India

    The foremost challenge for any pharma company with biotech divisions or units in the Asian region is bringing out the product. We do not have too many products. However, I have been convinced that at least some Indian companies will do it.

  • 26 April 2010
    Liraglutide Superior to Sitagliptin When Added to Metformin for Glycemic Control

    The addition of a glucagonlike peptide-1 (GLP-1) agonist in patients with inadequate glycemic control when treated with metformin alone resulted in significantly larger reductions in HbA1c levels when compared with the addition of a dipeptidyl peptidase-4 (DPP-4) inhibitor, a new study has shown.

  • 26 April 2010
    FDA Launches Campaign to Improve Infusion-Pump Safety

    The US Food and Drug Administration (FDA) today unveiled an ambitious campaign to improve the safety of external infusion pumps, which have triggered 56,000 FDA adverse event reports linked to more than 500 deaths and 87 product recalls from 2005 through 2009, according to the agency.

    The campaign mostly affects the makers of external infusion pumps, which may find FDA inspectors visiting their plants to ensure that safe manufacturing and testing processes are in place.

  • 22 April 2010
    IPA to conduct panel discussion on: how to handle expired drugs, next month

    In the wake of the present expired drugs scam that plagued the entire pharma industry in Tamil Nadu, the Industry Division of the Indian Pharmaceutical Association plans to conduct a Panel Discussion on ‘How to Handle the Expired Drugs’. The programme will be conducted in Chennai in the first week of next month.

  • 22 April 2010
    3G technology to revolutionize Indian healthcare space: Vishal Bali

    The introduction of 3G technology will change the face of healthcare delivery and the huge wave of 3G licenses and its impact on healthcare will be exponential. The availability of 3G bandwidth will enable video broadcast and data-intensive services telemedicine through wireless communications which will help accessibility of medical care to patients in far flung areas, said Vishal Bali, CEO Fortis Hospital.

  • 22 April 2010
    FDA warning to Propylthiouracil

    April 21, 2010 — The US Food and Drug Administration (FDA) has added a boxed warning to the drug label for propylthiouracil about reports of severe liver injury and acute liver failure, in some cases fatal, that have been reported in both adult and pediatric patients who used this drug.

    Notice of the warning was sent today in an alert from MedWatch, the FDA's safety information and adverse event reporting program.

    [adsense:336x280:8701650588]

  • 22 April 2010
    Pharmexcil urges PM to extend sunset clause till March 2015 for pharma SEZs

    The Pharmaceutical Exports Promotion Council (Pharmexcil) has urged prime minister Dr Manmohan Singh to extend the income tax benefits offered for the pharma Special Economic Zones (SEZs) under section 10 B, the sunset clause, under the Income Tax Act to four more years till the year 2015 for the existing units, in an effort to support the pharmaceutical exporters in the country.

  • 21 April 2010
    Early vs Late Tracheotomy May Not Lower Ventilator-Associated Pneumonia Risk

    April 20, 2010 — Early vs late tracheotomy (6 - 8 days vs 13 - 15 days after mechanical ventilation) may not significantly lower the risk for ventilator-associated pneumonia in adult patients in the intensive care unit (ICU), according to the results of a randomized controlled trial reported in the April 21 issue of the Journal of the American Medical Association.

  • 21 April 2010
    CDC Report Confirms Pregnant Women at Increased Risk for H1N1 Death

    Pregnant women infected with the 2009 influenza A (H1N1) virus are at increased risk for death compared with others, but treatment within 2 days of symptom onset decreased this risk, according to a study by the Centers for Disease Control and Prevention (CDC), published in the April 21 issue of the Journal of the American Medical Association.

  • 21 April 2010
    Celgene forms strategic collaboration with Agios to advance unique science of cancer metabolism

    Celgene Corporation and Agios Pharmaceuticals Inc, a privately-held biotechnology company, announced the formation of a global strategic collaboration focused on targeting cancer metabolism. The goal of the collaboration is to discover, develop, and deliver novel disease-altering therapies in oncology based on the transformational science of Agios' innovative cancer metabolism research platform. This platform is based on the concept that targeting key metabolic enzymes unique to rapidly proliferating cancer cells can "starve" the cancer.

Subscribe to Pharma News